EMA vs TAC
Emera Incorporated and Transalta Corporation, side by side — 10 fiscal years reported in CAD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | EMA | TAC |
|---|---|---|
| Revenue | CAD 8.8B | CAD 2.4B |
| Net income | CAD 1.1B | CAD -138.0M |
| Gross margin | — | 59.0% |
| Net margin | 12.4% | −5.7% |
| Return on equity | 8.2% | −8.8% |
| Diluted EPS | CAD 3.38 | −CAD 0.64 |
| Dividend / share | CAD 2.91 | — |
| Payout ratio | 52.8% | — |
| Free cash flow | CAD -1.7B | CAD 397.0M |
| Equity | CAD 13.4B | CAD 1.4B |
| Net debt / equity | 1.62× | 2.42× |
| Current ratio | 0.66× | 0.73× |
| Revenue CAGR 5y | 9.8% | 2.7% |
| Profit CAGR 5y | 2.1% | — |
EMA bills 3.6× the revenue of TAC, and TAC closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | EMA | TAC |
|---|---|---|
| FY2025 | CAD 8.8B | CAD 2.4B |
| FY2024 | CAD 7.2B | CAD 2.8B |
| FY2023 | CAD 7.6B | CAD 3.4B |
| FY2022 | CAD 7.6B | CAD 3.0B |
| FY2021 | CAD 5.8B | CAD 2.7B |
| FY2020 | CAD 5.5B | CAD 2.1B |
| FY2019 | CAD 6.1B | CAD 2.3B |
| FY2018 | CAD 6.5B | CAD 2.2B |
| FY2017 | CAD 6.2B | CAD 2.3B |
| FY2016 | CAD 4.3B | CAD 2.4B |
Net income by year
Bottom line
| Fiscal year | EMA | TAC |
|---|---|---|
| FY2025 | CAD 1.1B | CAD -138.0M |
| FY2024 | CAD 568.0M | CAD 229.0M |
| FY2023 | CAD 1.0B | CAD 695.0M |
| FY2022 | CAD 1.0B | CAD 50.0M |
| FY2021 | CAD 561.0M | CAD -537.0M |
| FY2020 | CAD 984.0M | CAD -287.0M |
| FY2019 | CAD 710.0M | CAD 82.0M |
| FY2018 | CAD 747.0M | CAD -198.0M |
| FY2017 | CAD 299.0M | CAD -160.0M |
| FY2016 | CAD 227.0M | CAD 169.0M |
Advertisement
AdSense · Rectangle 336×280